NDC 68788-9809-01 - LISINOPRIL AND HYDROCHLOROTHIAZIDE

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 68788-9809
Requested NDC: 68788-9809-01
Package NDCs from labels: 68788-9809-3, 68788-9809-6, 68788-9809-9, 68788-9809-1, 68788-9809-01
Manufacturer: Preferred Pharmaceuticals, Inc.
Effective date: 2026-05-22
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS USP	Preferred Pharmaceuticals, Inc.	2026-05-22	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
68788-9809-1	LISINOPRIL AND HYDROCHLOROTHIAZIDE	100 in 1 BOTTLE	TABLET	100	13
68788-9809-3	LISINOPRIL AND HYDROCHLOROTHIAZIDE	30 in 1 BOTTLE	TABLET	30	13
68788-9809-6	LISINOPRIL AND HYDROCHLOROTHIAZIDE	60 in 1 BOTTLE	TABLET	60	13
68788-9809-9	LISINOPRIL AND HYDROCHLOROTHIAZIDE	90 in 1 BOTTLE	TABLET	90	13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68788-9809	LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	11	Current NDC, Legacy NDC, 4 package rows	20240621_5aa18b0b-4688-493a-a5ae-cb056ea6c0e3.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
HYDROCHLOROTHIAZIDE	ACTIVE INGREDIENT	0J48LPH2TH	LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
LISINOPRIL	ACTIVE INGREDIENT	E7199S1YWR	LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
HYDROCHLOROTHIAZIDE	ACTIVE MOIETY	0J48LPH2TH	LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
LISINOPRIL ANHYDROUS	ACTIVE MOIETY	7Q3P4BS2FD	LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS	INACTIVE INGREDIENT	L11K75P92J	LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.]	2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 15 of 44 · 864 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Valsartan and Hydrochlorothiazide	VALSARTAN AND HYDROCHLOROTHIAZIDE	Northwind Health Company, LLC	db118092-2002-7a55-e053-2a95a90a7b2c	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	Northwind Health Company, LLC	f331769a-ff11-6c68-e053-2a95a90a493b	2026-01-01	Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH
Valsartan and Hydrochlorothiazide	VALSARTAN AND HYDROCHLOROTHIAZIDE	Northwind Health Company, LLC	db4d84ce-cf51-61dc-e053-2a95a90a2cfd	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH
LISINOPRIL	LISINOPRIL	Northwind Health Company, LLC	db98aaba-5925-f81b-e053-2a95a90a4879	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: E7199S1YWR
Lisinopril	LISINOPRIL	Northwind Health Company, LLC	f2b42895-ae25-2d2b-e053-2995a90a899a	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: E7199S1YWR
Lisinopril	LISINOPRIL	Northwind Health Company, LLC	c16edad6-423b-6ff0-e053-2a95a90a0240	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: E7199S1YWR
Lisinopril and Hydrochlorothiazide	LISINOPRIL AND HYDROCHLOROTHIAZIDE	Northwind Health Company, LLC	f2b94985-c79d-40e3-e053-2a95a90a0d78	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: ANDA077912 rxcui: 197886 unii: E7199S1YWR unii: 0J48LPH2TH
Lisinopril and Hydrochlorothiazide	LISINOPRIL AND HYDROCHLOROTHIAZIDE	Northwind Health Company, LLC	c97e38f2-7163-4d4e-a694-4d0612423e53	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: ANDA077912 rxcui: 197885 unii: E7199S1YWR unii: 0J48LPH2TH
Hydrochlorothiazide	HYDROCHLOROTHIAZIDE	Northwind Health Company, LLC	f2f3b60a-bffe-2675-e053-2995a90ae96e	2026-01-01	Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH
Lisinopril	LISINOPRIL	Northwind Health Company, LLC	6515d800-be95-4a70-ab1e-b4000708dd20	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: E7199S1YWR
Hydrochlorothiazide	HYDROCHLOROTHIAZIDE	Northwind Health Company, LLC	f7091c54-0984-7f6e-e053-6394a90afb4d	2026-01-01	Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH
Lisinopril	LISINOPRIL	Northwind Health Company, LLC	e3b14778-a57e-51d5-e053-2a95a90a9aad	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: E7199S1YWR
Lisinopril	LISINOPRIL	Northwind Health Company, LLC	e3b29545-6ba5-6bf5-e053-2995a90ae7de	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: E7199S1YWR
Lisinopril	LISINOPRIL	Northwind Health Company, LLC	f7f78491-bb4f-7ae7-e053-6394a90aff6f	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: E7199S1YWR
Hydrochlorothiazide	HYDROCHLOROTHIAZIDE	Northwind Health Company, LLC	f68d211d-d802-6c78-e053-2995a90a90d7	2026-01-01	Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH
Lisinopril and Hydrochlorothiazide	LISINOPRIL AND HYDROCHLOROTHIAZIDE	Northwind Health Company, LLC	3984e6b9-2d88-47f0-af09-cce428bba14f	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: ANDA077912 rxcui: 197887 unii: E7199S1YWR unii: 0J48LPH2TH
Triamterene and Hydrochlorothiazide	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	Northwind Health Company, LLC	db895e64-3f97-9201-e053-2a95a90ac7ef	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH
OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE	Solco Healthcare US, LLC	bdca31d3-60b1-4659-aef7-56530b4f9039	2025-12-31	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH
Dermagesic	PRAMOXINE HCL, ZINC OXIDE, CALAMINE	Llorens Pharmaceutical International Division	bbff6b53-29da-45c1-8ccd-3e9df7f250e0	2025-12-31	Warnings	Exact identifier unii: 1K09F3G675
Losartan Potassium and Hydrochlorothiazide	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	A-S Medication Solutions	bc8b9ae2-8263-4624-8629-4f856392f9da	2025-12-30	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.